Gilead Sciences Inc DRC (GILD)

Toronto

Currency in CAD

30.06

-0.48(-1.57%)

Closed·30/09

Fair Value

Unlock Value

Day's Range

30.06

30.18

52 wk Range

22.49

31.80

GILD Income Statement

Assess the Gilead Sciences DRC income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the GILD net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

27,305

27,281

27,116

28,754

29,443

Total Revenues Growth

aa.aa

+10.6%

-0.09%

-0.6%

+6.04%

+2.4%

Cost Of Revenues

aa.aa

5,526

5,657

5,968

6,251

6,230

Gross Profit

aa.aa

21,779

21,624

21,148

22,503

23,213

Gross Profit Growth

aa.aa

+3.72%

-0.71%

-2.2%

+6.41%

+3.16%

Gross Profit Margin %

aa.aa

79.76%

79.26%

77.99%

78.26%

78.84%

Other Operating Expenses, Total

aa.aa

9,847

10,650

11,820

11,816

11,396

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-1.91%	+8.15%	+10.99%	-0.03%	-3.55%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4,601	4,977	5,758	5,816	5,688
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	5,246	5,673	6,062	6,000	5,708
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

11,932

10,974

9,328

10,687

11,817

Operating Income Growth

aa.aa

+8.88%

-8.03%

-15%

+14.57%

+10.57%

EBIT Margin %

aa.aa

43.7%

40.23%

34.4%

37.17%

40.14%

Net Interest Expenses

aa.aa

-1,001

-829

-568

-696

-675

Net Interest Expenses Growth

aa.aa

-1.73%

+17.18%

+31.48%

-22.54%

+3.02%

Interest Expense, Total

aa.aa

-1,001

-935

-944

-977

-1,024

Interest And Investment Income

aa.aa

106

376

281

349

Other Non Operating Expenses, Total

aa.aa

-29

-30

-10

-1

-2

EBT, Excl. Unusual Items

aa.aa

10,902

10,115

8,750

9,990

11,140

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-2,014

-3,644

-1,196

-8,836

-1,657

EBT, Incl. Unusual Items

aa.aa

8,278

5,814

6,860

691

9,796

EBT, Incl. Unusual Items Growth

aa.aa

+395.99%

-29.77%

+17.99%

-89.93%

+1,317.66%

EBT, Incl. Unusual Items Margin

aa.aa

30.32%

21.31%

25.3%

2.4%

33.27%

Income Tax Expense

aa.aa

2,077

1,248

1,247

211

1,286

Net Income to Company

aa.aa

6,201

4,566

5,613

480

8,510

Minority Interest

aa.aa

Net Income

aa.aa

6,225

4,592

5,665

480

8,510

Net Income Growth

aa.aa

+4,960.98%

-26.23%

+23.37%

-91.53%

+1,672.92%

Net Income Margin %

aa.aa

22.8%

16.83%

20.89%

1.67%

28.9%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

6,225

4,592

5,665

480

8,510

Basic EPS - Continuing Operations

aa.aa

4.96

3.66

4.54

0.38

6.84

Basic EPS - Continuing Operations Growth

aa.aa

+4,965.01%

-26.17%

+24.06%

-91.52%

+1,677.2%

Diluted EPS - Continuing Operations

aa.aa

4.93

3.64

4.5

0.38

6.78

Diluted EPS - Continuing Operations Growth

aa.aa

+4,938.22%

-26.17%

+23.63%

-91.56%

+1,684.21%

Basic Weighted Average Shares Outstanding

aa.aa

1,256

1,255

1,248

1,247

1,244

Diluted Weighted Average Shares Outstanding

aa.aa

1,262

1,258

1,255

Dividend Per Share

aa.aa

2.84

2.92

3.08

3.16

Dividend Per Share Growth

aa.aa

+4.41%

+2.82%

+2.74%

+2.67%

+2.6%

EBITDA

aa.aa

13,982

13,077

12,021

13,454

14,577

EBITDA Growth

aa.aa

+12.4%

-6.47%

-8.08%

+11.92%

+8.35%

EBITDA Margin %

aa.aa

51.21%

47.93%

44.33%

46.79%

49.51%

EBIT

aa.aa

11,932

10,974

9,328

10,687

11,817

* In Millions of USD (except for per share items)

FAQ

What was Gilead Sciences DRC’s revenue at year end?

At the end of the last reported fiscal year, Gilead Sciences DRC (GILD) recorded total revenue of 29,443.00 million USD.

How much revenue did Gilead Sciences DRC report in the most recent quarter?

In its most recent quarterly earnings report, Gilead Sciences DRC posted revenue of 7,803.00 million USD.

What was Gilead Sciences DRC’s net income for the year?

For the full year, Gilead Sciences DRC reported net income of 8,510.00 million USD.

How much net income did Gilead Sciences DRC post in the last quarter?

In the most recent quarter, Gilead Sciences DRC (GILD) posted net income of -10,496.00 million USD.

What was Gilead Sciences DRC’s gross profit for the year?

Gross profit for the year was reported at 23,213.00 million USD.

How much gross profit did Gilead Sciences DRC generate last quarter?

Gilead Sciences DRC recorded gross profit of 6,224.00 million USD in its latest quarterly report.

What was Gilead Sciences DRC’s annual operating income?

For the full year, Gilead Sciences DRC (GILD) reported operating income of 11,817.00 million USD.

What was Gilead Sciences DRC’s operating income last quarter?

Quarterly operating income was 2,628.00 million USD.

What was Gilead Sciences DRC’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 3,326.00 million USD.

What was the quarter-over-quarter change in EBITDA for Gilead Sciences DRC?

EBITDA changed by -2.83% million USD compared to the last quarter.

What is Gilead Sciences DRC’s most recent gross profit margin?

The latest reported gross profit margin for Gilead Sciences DRC (GILD) is 79.76% million USD.

What is Gilead Sciences DRC’s most recent net income margin?

Net income margin based on recent financials is -134.51% million USD.

What is Gilead Sciences DRC’s most recent EBIT margin?

Gilead Sciences DRC reported an EBIT margin of 33.68% million USD based on current figures.

How did Gilead Sciences DRC’s revenue change compared to the previous quarter?

Revenue changed by 12.11% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Gilead Sciences DRC?

In the latest quarter, gross profit changed by 12.86% million USD from the previous quarter.

S&P/TSX

35,235.87

-224.40

-0.63%

S&P/TSX 60

2,071.65

-14.54

-0.70%

US 30

50,990.60

+81.8

+0.16%

US 500

7,695.00

+43.0

+0.56%

S&P 500 VIX

16.34

+0.30

+1.87%

DAX

25,199.19

-200.02

-0.79%

Dollar Index

101.38

+0.189

+0.19%

Market Movers

Name	Last	Chg. %	Vol.
RBC	279.94	-1.18%	2.56M
Canadian Natural	66.93	+0.03%	8.69M
Shopify Inc	210.92	+0.42%	2.01M
Franco-Nevada	338.80	-3.78%	1.24M
First Quantum Minerals	38.23	-15.27%	10.21M
Toronto Dominion Bank	167.33	-0.89%	2.31M
Suncor Energy	96.50	+0.71%	3.57M

Name	Last	Chg. %	Vol.
Carson River Ventures	0.11	+266.67%	30.50K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Biomind Labs	0.80	+100.00%	4.70K
Greenhawk Resources	0.0200	+100.00%	11.33K
Greenhawk Resources	0.02	+100.00%	11.33K
Affinity Metals	0.050	+100.00%	11.00K
ePlay Digital	0.010	+100.00%	7.00K

Name	Last	Chg. %	Vol.
TrustBIX	0.01	-100.00%	1.00K
Beckett’s	0.01	-100.00%	4.00K
SP Strategic Acquisition	0.02	-66.67%	57.97K
Lanebury Growth Capital	0.06	-63.33%	4.00K
Biosenta Inc	0.040	-55.56%	1.00K
Beckett’s	0.005	-50.00%	4.00K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
TELUS	11.95	+3.28%	13.54M
Hut 8	122.540	-6.98%	467.81K
BCE Inc	28.97	+1.22%	3.75M
Toronto Dominion Bank	167.33	-0.89%	2.31M
Celestica Inc.	514.95	-0.82%	335.10K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaaa A	16.32	+76.23%	28.76
Aaaaaaaaaaaaaaa	16.00	+57.00%	25.12
Aaaaaaaaaaa A	96.75	+54.17%	149.16
Aaaaa Aaaaaaaaa	16.80	+52.38%	25.60
Aaaaaa Aaa	9.400	+49.49%	14.052
Aaaaaaaaaaa	2.3500	+49.37%	3.5101
Aaaaaaaaaa Aa	31.91	+48.61%	47.42

Name	Last	Upside	Fair Value
A Aaaa A	16.32	+76.23%	28.76
Aaaaaaaaaaaaaaa	16.00	+57.00%	25.12
Aaaaaaaaaaa A	96.75	+54.17%	149.16
Aaaaa Aaaaaaaaa	16.80	+52.38%	25.60
Aaaaaa Aaa	9.400	+49.49%	14.052
Aaaaaaaaaaa	2.3500	+49.37%	3.5101
Aaaaaaaaaa Aa	31.91	+48.61%	47.42

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Gilead Sciences Inc DRC (GILD)

GILD Income Statement

FAQ

What was Gilead Sciences DRC’s revenue at year end?

How much revenue did Gilead Sciences DRC report in the most recent quarter?

What was Gilead Sciences DRC’s net income for the year?

How much net income did Gilead Sciences DRC post in the last quarter?

What was Gilead Sciences DRC’s gross profit for the year?

How much gross profit did Gilead Sciences DRC generate last quarter?

What was Gilead Sciences DRC’s annual operating income?

What was Gilead Sciences DRC’s operating income last quarter?

What was Gilead Sciences DRC’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Gilead Sciences DRC?

What is Gilead Sciences DRC’s most recent gross profit margin?

What is Gilead Sciences DRC’s most recent net income margin?

What is Gilead Sciences DRC’s most recent EBIT margin?

How did Gilead Sciences DRC’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Gilead Sciences DRC?

Trending Stocks